Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
EYEGENE is a biotechnology company specializing in the development of vaccines and therapeutics. Its core business involves the development of novel drugs for a range of diseases, including a shingles vaccine, a cervical cancer vaccine, and a therapeutic for diabetic retinopathy. Specifically, EYEGENE is committed to preventing infectious diseases and treating intractable diseases by leveraging its RNA-based vaccine platform technology.
아이진은 백신 및 치료제 개발을 전문으로 하는 바이오 기업입니다. 주요 사업 영역은 대상포진 백신, 자궁경부암 백신, 당뇨망막병증 치료제 등 다양한 질병에 대한 신약 개발입니다. 특히 RNA 기반 백신 플랫폼 기술을 활용하여 감염병 예방 및 난치성 질환 치료에 주력하고 있습니다.
